Literature DB >> 29427449

Butyrated ManNAc analog improves protein expression in Chinese hamster ovary cells.

Bojiao Yin1, Qiong Wang1, Cheng-Yu Chung1, Xiaozhi Ren1, Rahul Bhattacharya2, Kevin J Yarema2, Michael J Betenbaugh1.   

Abstract

The chemical additive sodium butyrate (NaBu) has been applied in cell culture media as a direct and convenient method to increase the protein expression in Chinese hamster ovary (CHO) and other mammalian cells. In this study, we examined an alternative chemical additive, 1,3,4-O-Bu3 ManNAc, for its effect on recombinant protein production in CHO. Supplementation with 1,3,4-O-Bu3 ManNAc for two stable CHO cell lines, expressing human erythropoietin or IgG, enhanced protein expression for both products with negligible impact on cell growth, viability, glucose utilization, and lactate accumulation. In contrast, sodium butyrate treatment resulted in a ∼20% decrease in maximal viable cell density and ∼30% decrease in cell viability at the end of cell cultures compared to untreated or 1,3,4-O-Bu3 ManNAc treated CHO cell lines for both products. While NaBu treatment enhanced product yields more than the 1,3,4-O-Bu3 ManNAc treatment, the NaBu treated cells also exhibited higher levels of caspase 3 positive cells using microscopy analysis. Furthermore, the mRNA levels of four cell apoptosis genes (Cul2, BAK, BAX, and BCL2L11) were up-regulated more in sodium butyrate treated wild-type, erythropoietin, or IgG expressing CHO-K1 cell lines while most of the mRNA levels of apoptosis genes in 1,3,4-O-Bu3 ManNAc treated cell lines remained equal or increased only slightly compared to the levels in untreated CHO cell lines. Finally, lectin blot analysis revealed that the 1,3,4-O-Bu3 ManNAc-treated cells displayed higher relative sialylation levels on recombinant EPO, consistent with the effect of the ManNAc component of this additive, compared to control while NaBu treatment led to lower sialylation levels than control, or 1,3,4-O-Bu3 ManNAc-treatment. These findings demonstrate that 1,3,4-O-Bu3 ManNAc has fewer negative effects on cell cytotoxicity and apoptosis, perhaps as a result of a more deliberate uptake and release of the butyrate compounds, while simultaneously increasing the expression of multiple recombinant proteins, and improving the glycosylation characteristics when applied at comparable molarity levels to NaBu. Thus, 1,3,4-O-Bu3 ManNAc represents a highly promising media additive alternative in cell culture for improving protein yields without sacrificing cell mass and product quality in future bioproduction processes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHO cells; ManNAc analog; antibody recombinant protein expression; sialylation; sodium butyrate

Mesh:

Substances:

Year:  2018        PMID: 29427449     DOI: 10.1002/bit.26560

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

1.  Exploiting metabolic glycoengineering to advance healthcare.

Authors:  Christian Agatemor; Matthew J Buettner; Ryan Ariss; Keerthana Muthiah; Christopher T Saeui; Kevin J Yarema
Journal:  Nat Rev Chem       Date:  2019-09-06       Impact factor: 34.035

2.  Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.

Authors:  Qiong Wang; Ganglong Yang; Tiexin Wang; Weiming Yang; Michael J Betenbaugh; Hui Zhang
Journal:  Biotechnol Bioeng       Date:  2019-05-29       Impact factor: 4.530

Review 3.  Decoding glycans: deciphering the sugary secrets to be coherent on the implication.

Authors:  Shreya Sharma; Shashank Shekhar; Bhasha Sharma; Purnima Jain
Journal:  RSC Adv       Date:  2020-09-15       Impact factor: 4.036

4.  Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter.

Authors:  Hussain Dahodwala; Prashant Kaushik; Vijay Tejwani; Chih-Chung Kuo; Patrice Menard; Michael Henry; Bjorn G Voldborg; Nathan E Lewis; Paula Meleady; Susan T Sharfstein
Journal:  Curr Res Biotechnol       Date:  2019-10-05

5.  Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability.

Authors:  Fatemeh Safari; Safar Farajnia; Abbas Behzad Behbahani; Habib Zarredar; Mazyar Barekati-Mowahed; Hesam Dehghani
Journal:  Biol Res       Date:  2020-11-13       Impact factor: 5.612

Review 6.  Serum-Free Medium for Recombinant Protein Expression in Chinese Hamster Ovary Cells.

Authors:  Weifeng Li; Zhenlin Fan; Yan Lin; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-03-15

7.  Violacein improves recombinant IgG production by controlling the cell cycle of Chinese hamster ovary cells.

Authors:  Masahide Kido; Hideaki Idogaki; Kouji Nishikawa; Takeshi Omasa
Journal:  Cytotechnology       Date:  2020-11-23       Impact factor: 2.040

Review 8.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.